NYSE:PNTM Pontem (PNTM) Stock Forecast, Price & News Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$10.37▼$10.3750-Day Range$10.35▼$10.4852-Week Range$9.79▼$10.49Volume59 shsAverage Volume202,738 shsMarket Capitalization$438.03 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media About Pontem (NYSE:PNTM) StockPontem Corporation does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to focus its search on global and regional consumer brands businesses. Pontem Corporation was incorporated in 2020 and is based in New York, New York.Read More PNTM Stock News HeadlinesMay 17, 2023 | marketwatch.com8-K: Pontem CorpMay 16, 2023 | seekingalpha.comSPAC Pontem to liquidate around May 30 due to lack of mergerSeptember 21, 2023 | The Oxford Club (Ad)Better Than Oil Stocks?The best way to profit from energy is NOT a stock...Rather, it's this little-known alternative investment. May 15, 2023 | finance.yahoo.comPontem Corporation will redeem its Public Shares and will not consummate an initial business combinationJanuary 22, 2023 | wsj.comPontem Corp.January 13, 2023 | marketwatch.comSPAC Pontem's Deadline to Merge with Industrial Tech Company ExtendedJanuary 13, 2023 | finance.yahoo.comPontem Corporation Confirms Shareholder Approval of Extension of Deadline to Complete Initial Business CombinationJanuary 5, 2023 | seekingalpha.comSPAC Pontem enters in to LOI for merger with large industrial tech companySeptember 21, 2023 | Behind the Markets (Ad)The single greatest medical breakthrough of all time?We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.January 5, 2023 | finance.yahoo.comPontem Corporation (PNTM-UN)October 26, 2022 | wsj.comPontem Corp. Cl ASeptember 26, 2022 | benzinga.comPontem Stock (NYSE:PNTM), Earnings Estimates, EPS, and RevenueAugust 14, 2022 | investing.comPNTM_u Technical AnalysisMay 4, 2022 | finance.yahoo.comPontem Corporation (PNTM-WT)March 3, 2022 | za.investing.comPontem Corp (PNTM_u)November 29, 2021 | finance.yahoo.comWhat Is The Ownership Structure Like For Pontem Corporation (NYSE:PNTM)?November 29, 2021 | finance.yahoo.comStemming from SEC Guidance Concerning Balance Sheet Treatment of Warrants, Pontem Corporation Announces Receipt of NYSE Continued Listing Standard NoticeSee More Headlines Receive PNTM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Pontem and its competitors with MarketBeat's FREE daily newsletter. Email Address PNTM Company Calendar Today9/21/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE Industry Holding & other investment offices Sub-IndustryN/A SectorUnclassified Current SymbolNYSE:PNTM CUSIPN/A CIK1830392 Webwww.pontemcorp.com Phone212-457-9077FaxN/AEmployees2Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$34.84 million Net MarginsN/A Pretax MarginN/A Return on Equity-54.26% Return on Assets3.08% Debt Debt-to-Equity RatioN/A Current Ratio0.16 Quick Ratio0.16 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash Flow$2.02 per share Price / Cash Flow5.13 Book Value($0.85) per share Price / Book-12.20Miscellaneous Outstanding Shares42,240,000Free Float42,160,000Market Cap$438.03 million OptionableNot Optionable Beta0.03 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Hubertus Michael Muehlhaeuser Esq. (Age 53)Chairman & CEO Ms. Nina Murphy (Age 44)Chief Financial Officer Key CompetitorsDecarbonization Plus Acquisition Co. IVNASDAQ:DCRDTortoiseEcofin Acquisition Corp. IIINYSE:TRTLEnphys AcquisitionNYSE:NFYSHennessy Capital Investment Corp. VINASDAQ:HCVINabors Energy Transition Corp. IINASDAQ:NETDView All Competitors PNTM Stock - Frequently Asked Questions What is Pontem's stock symbol? Pontem trades on the New York Stock Exchange (NYSE) under the ticker symbol "PNTM." What is Pontem's stock price today? One share of PNTM stock can currently be purchased for approximately $10.37. How much money does Pontem make? Pontem (NYSE:PNTM) has a market capitalization of $438.03 million. How can I contact Pontem? Pontem's mailing address is 1140 Avenue of the Americas 9th Floor, New York NY, 10036. The official website for the company is www.pontemcorp.com. The company can be reached via phone at 212-457-9077. This page (NYSE:PNTM) was last updated on 9/21/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pontem Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.